These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1907256)

  • 1. Liver macrophage-mediated cytotoxicity toward mastocytoma cells involves phagocytosis of tumor targets.
    Gardner CR; Wasserman AJ; Laskin DL
    Hepatology; 1991 Aug; 14(2):318-24. PubMed ID: 1907256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential sensitivity of tumor targets to liver macrophage-mediated cytotoxicity.
    Gardner CR; Wasserman AJ; Laskin DL
    Cancer Res; 1987 Dec; 47(24 Pt 1):6686-91. PubMed ID: 3119198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IFN-gamma differentially modulates the susceptibility of L1210 and P815 tumor targets for macrophage-mediated cytotoxicity. Role of macrophage-target interaction coupled to nitric oxide generation, but independent of tumor necrosis factor production.
    Leu RW; Leu NR; Shannon BJ; Fast DJ
    J Immunol; 1991 Sep; 147(6):1816-22. PubMed ID: 1909732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The third component of complement (C3) bound to tumor target cells enhances their sensitivity to killing by activated macrophages.
    Bara S; Lint TF
    J Immunol; 1987 Feb; 138(4):1303-9. PubMed ID: 3100634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of target recognition and destruction in macrophage-mediated tumor cytotoxicity.
    Adams DO; Johnson WJ; Marino PA
    Fed Proc; 1982 Apr; 41(6):2212-21. PubMed ID: 6804274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody-mediated erythrolysis and erythrophagocytosis by human monocytes, macrophages and activated macrophages. Evidence for distinction between involvement of high-affinity and low-affinity receptors for IgG by using different erythroid target cells.
    Rüegg SJ; Jungi TW
    Immunology; 1988 Mar; 63(3):513-20. PubMed ID: 2965100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrophage-mediated, antibody-dependent destruction of tumor cells in DBA/2 mice: in vitro identification of an in situ mechanism.
    Key M; Haskill S
    J Natl Cancer Inst; 1981 Jan; 66(1):103-10. PubMed ID: 7005500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential expression of murine macrophage-mediated tumor cytotoxicity induced by interferons.
    Koestler TP; Johnson WJ; Rieman D; Dalton BJ; Greig RG; Poste G
    Cancer Res; 1987 Jun; 47(11):2804-8. PubMed ID: 2436758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Taxol provides a second signal for murine macrophage tumoricidal activity.
    Manthey CL; Perera PY; Salkowski CA; Vogel SN
    J Immunol; 1994 Jan; 152(2):825-31. PubMed ID: 7506736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spontaneous cytotoxicity of macrophages against pancreatic islet cells.
    Appels B; Burkart V; Kantwerk-Funke G; Funda J; Kolb-Bachofen V; Kolb H
    J Immunol; 1989 Jun; 142(11):3803-8. PubMed ID: 2654293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular models of macrophage tumoricidal effector mechanisms in vitro. Characterization of cytolytic responses to tumor necrosis factor and nitric oxide pathways in vitro.
    Klostergaard J; Leroux ME; Hung MC
    J Immunol; 1991 Oct; 147(8):2802-8. PubMed ID: 1918993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. M2 macrophages phagocytose rituximab-opsonized leukemic targets more efficiently than m1 cells in vitro.
    Leidi M; Gotti E; Bologna L; Miranda E; Rimoldi M; Sica A; Roncalli M; Palumbo GA; Introna M; Golay J
    J Immunol; 2009 Apr; 182(7):4415-22. PubMed ID: 19299742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High strength binding of P815 mastocytoma cells is not necessary for their lysis by macrophages which have been primed and triggered in vitro.
    Lu CY; Lombardi MJ; Shea CM; Dustin LB
    J Immunol; 1988 Aug; 141(4):1083-90. PubMed ID: 3135320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of tumor cell capture by activated macrophages: evidence for involvement of lymphocyte function-associated (LFA)-1 antigen.
    Strassmann G; Springer TA; Somers SD; Adams DO
    J Immunol; 1986 Jun; 136(11):4328-33. PubMed ID: 2422281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phagocytosis of apoptotic cells assessed by flow cytometry using 7-Aminoactinomycin D.
    Gaforio JJ; Serrano MJ; Algarra I; Ortega E; Alvarez de Cienfuegos G
    Cytometry; 2002 Sep; 49(1):8-11. PubMed ID: 12210605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phagocytosis of apoptotic cells by human macrophages: analysis by multiparameter flow cytometry.
    Jersmann HP; Ross KA; Vivers S; Brown SB; Haslett C; Dransfield I
    Cytometry A; 2003 Jan; 51(1):7-15. PubMed ID: 12500300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor cell surface expression of granulocyte-macrophage colony-stimulating factor elicits antitumor immunity and protects from tumor challenge in the P815 mouse mastocytoma tumor model.
    Soo Hoo W; Lundeen KA; Kohrumel JR; Pham NL; Brostoff SW; Bartholomew RM; Carlo DJ
    J Immunol; 1999 Jun; 162(12):7343-9. PubMed ID: 10358185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The cytolytic function of mononuclear phagocytes. II. Factors that determine the binding and lysis of tumor cells by activated macrophages].
    Vasil'ev VIu; Krotkova MV; Popova EV; Shatrova AN
    Tsitologiia; 1990; 32(3):275-81. PubMed ID: 2219450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phagocytosis of breast cancer cells mediated by anti-MUC-1 monoclonal antibody, DF3, and its bispecific antibody.
    Akewanlop C; Watanabe M; Singh B; Walker M; Kufe DW; Hayes DF
    Cancer Res; 2001 May; 61(10):4061-5. PubMed ID: 11358826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ex vivo-activated human macrophages kill chronic lymphocytic leukemia cells in the presence of rituximab: mechanism of antibody-dependent cellular cytotoxicity and impact of human serum.
    Lefebvre ML; Krause SW; Salcedo M; Nardin A
    J Immunother; 2006; 29(4):388-97. PubMed ID: 16799334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.